Frailty Scores and Their Utility in Older Patients with Cardiovascular Disease

Area of Science:

• Gerontology
• Cardiology
• Clinical Medicine

Background:

• Global population aging increases the number of frail individuals requiring cardiovascular disease (CVD) treatment.
• Novel interventions like transcatheter aortic valve implantation are treating older patients with CVD in later life stages.
• Assessing frailty is critical due to the growing burden of CVD in aging populations.

Purpose of the Study:

• To review the evidence on the utility of frailty assessment tools in patients with cardiovascular disease (CVD).
• To evaluate the impact of frailty on various measured outcomes in CVD patients.
• To address the lack of consensus on optimal frailty assessment tools for clinical use in CVD.

Main Methods:

• Systematic literature review of studies evaluating frailty assessment in CVD patients.
• Analysis of evidence on the association between frailty and CVD outcomes.
• Comparison of different validated frailty instruments and their clinical concordance.

Main Results:

• Growing evidence links frailty with adverse outcomes in cardiovascular disease (CVD) patients.
• Limited concordance exists between different validated frailty assessment instruments.
• The optimal tool for clinical frailty assessment in CVD remains undetermined.

Conclusions:

• Frailty assessment is increasingly important for managing cardiovascular disease (CVD) in aging populations.
• Further research is needed to establish a consensus on the best frailty assessment tool for clinical practice in CVD.
• Standardized frailty assessment can improve patient care and outcomes in cardiovascular disease.